Project Details
Description
The aim of this work will be to explore the use of sonication to disrupt the blood-brain barrier as a mean to enhance the delivery of therapeutic-cargo to high grade gliomas. Therapeutic cargo includes protein-based drug carriers that can be modified to include fluorescent tags and targeting proteins. Current therapeutic cargo being developed are IDP-micelles and MS2 capsids.
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/21 → 6/30/23 |
Funding
- University of California, San Francisco (UFRA-343 Amd 2)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.